actions mechanisms for HIV-1 integrase
anti-AIDS drugs
antiviral drug design
antiviral drugs
Category=MJ
Category=MK
Category=PN
Category=PS
designing anti-AIDs drugs
eq_bestseller
eq_isMigrated=1
eq_nobargain
eq_non-fiction
eq_science
HIV
HIV-1
HIV-1 integrase
inhibitor design for HIV-1 integrase
researchers in antiviral drug design
Product details
- ISBN 9780470184745
- Weight: 1465g
- Dimensions: 222 x 287mm
- Publication Date: 28 Oct 2011
- Publisher: John Wiley & Sons Inc
- Publication City/Country: US
- Product Form: Hardback
Secure
checkout
Fast Shipping
Easy returns
This book comprehensively covers the mechanisms of action and inhibitor design for HIV-1 integrase. It serves as a resource for scientists facing challenging drug design issues and researchers in antiviral drug discovery. Despite numerous review articles and isolated book chapters dealing with HIV-1 integrase, there has not been a single source for those working to devise anti-AIDS drugs against this promising target. But this book fills that gap and offers a valuable introduction to the field for the interdisciplinary scientists who will need to work together to design drugs that target HIV-1 integrase.
Nouri Neamati, PhD, is an Associate Professor of Pharmacology and Pharmaceutical Sciences at the University of Southern California School of Pharmacy. He is the recipient of numerous awards and has published more than 170 peer-reviewed manuscripts, several book chapters, and patents in the area of drug design and discovery. Dr. Neamati is the Editor-in-Chief of Current Molecular Pharmacology; an Associate Editor of Current Cancer Drug Targets; and an Editorial Advisory Board member of several journals including Expert Opinion on Drug Discovery, Expert Opinion on Investigational Drugs, and Hormones & Cancer.
